aprepitant - Compound Summary (CID 151165) Also known as: Emend, Aprepitant [USAN], MK 869, UNII-1NF15YR6UY, AC1L45SL, MK 0869, L 754030, DB00673, NCGC00181785-01 Molecular Formula: C 23H 21F 7N 4O 3 Molecular Weight: 534.426662 InChIKey: ATALOFNDEOCMKK-BYYRLHKVSA-N Aprepitant, an antiemetic, is a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. Aprepitant has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting (CI NV). From: DrugBank |
| | |
Identification Related Records Use and Manufacturing Pharmacology Literature Patents Biomolecular Interactions and Pathways Biological Test Results Classification Chemical and Physical Properties |